logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
N

Naoya Akazawa

Department of Gastroenterological Surgery
H指数:14
被引数:1,382

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical significance of WES-defined ERBB2 amplification in resectable colorectal cancer

WES定义的ERBB2扩增在可切除结直肠癌中的临床意义

International Journal of Clinical Oncology
IF2.8
2026-08-200
OAAI
Kazuki Kishi; Atsushi Hamabe; Yusuke Suwa; Naoya Akazawa; Keiji Hirata; Masataka Ikeda; Mitsuru Yokota; Kentaro Kato; Masahito Kotaka; Yujiro Nishizawa; Hideaki Bando; Yoshiaki Nakamura; Saori Mishima; Tadayoshi Hashimoto; Arkarachai Fungtammasan; Charuta C. Palsuledesai; Robert W. Lentz; Daisuke Kotani; Hiroya Taniguchi; Jun Watanabe; Ichiro Takemasa; Takeshi Kato; Mamoru Uemura; Hidetoshi Eguchi; Yuichiro Doki; Eiji Oki; Takayuki Yoshino
Plasma Biomarkers Associated with Clinical Outcomes of FOLFIRI Plus Ramucirumab in RAS Wild-Type Metastatic Colorectal Cancer: The JACCRO CC-16AR Trial

血浆生物标志物与FOLFIRI联合雷莫芦单抗在RAS野生型转移性结直肠癌中的临床结局关联：JACCRO CC-16AR试验

Targeted Oncology
IF4
2026-05-200
PRE
Yu Sunakawa; Hisateru Yasui; Manabu Shiozawa; Hiroyuki Takeda; Naoya Akazawa; Tamotsu Sagawa; Kazuhiro Shiraishi; Takahisa Kyogoku; Takashi Mine; Yasuhiro Yuasa; Takanori Watanabe; Tatsuya Kinjo; Yoshihiro Okita; Hiroyuki Okuyama; Satoshi Yuki; Koki Miyakawa; Ayana Kobara; Shoko Yanaka; Yukiko Abe; Wataru Ichikawa; Masashi Fujii; Akihito Tsuji
Evaluation of a novel standardized education program for centrally inserted central catheters insertion in a region of Japan

评估日本某地区经中心置入中心静脉导管置管的新型标准化教育项目

JOURNAL OF VASCULAR ACCESS
IF1.7
2026-05-010
PRE
Saijo, Fumito; Arata, Yutaro; Akazawa, Naoya; Oguro, Sota; Konno, Daisuke; Sato, Ami; Sato, Kaoru; Sawada, Kentaro; Tanaka, Rie; Mitamura, Atsushi; Miyasaka, Norihiro; Mutoh, Mitsuhisa; Muroya, Yoshikazu; Tsujinaka, Shingo; Omata, Kei; Tamagake, Naoto; Yokokawa, Yuta; Aoki, Takeshi; Toyama, Shingo; Egawa, Shinichi
Molecular Residual Disease and Recurrence in Rectal Cancer Patients Undergoing Upfront Surgery A Prospective Cohort Study: Erratum

直肠癌症患者接受根治性手术后的分子残留病灶与复发：前瞻性队列研究：勘误

Annals of Surgery
IF6.4
2026-04-090
PRE
Ando, Koji; Hamabe, Atsushi; Nakamura, Yoshiaki; Watanabe, Jun; Hirata, Keiji; Kataoka, Kozo; Miyo, Masaaki; Kato, Kentaro; Akazawa, Naoya; Kagawa, Yoshinori; Yokota, Mitsuru; Yamazaki, Kentaro; Mishima, Saori; Yukami, Hiroki; Kotani, Daisuke; Bando, Hideaki; Laliotis, George; Sharma, Shruti; Palsuledesai, Charuta C.; Rabinowitz, Matthew; Jurdi, Adham; Liu, Minetta C.; Aleshin, Alexey; Taniguchi, Hiroya; Takemasa, Ichiro; Kato, Takeshi; Yoshino, Takayuki; Oki, Eiji
Randomized phase II study of FOLFIRI plus ramucirumab versus FOLFOXIRI plus ramucirumab as first-line treatment for metastatic colorectal cancer: WJOG9216G (RECAST)

随机对照II期研究：FOLFIRI联合ramucirumab与FOLFOXIRI联合ramucirumab作为转移性结直肠癌一线治疗的比较：WJOG9216G（RECAST）

European Journal of Cancer
IF7.1
2026-03-190
OAAI
Yosuke Kito; Kentaro Yamazaki; Hirokazu Shoji; Takeshi Yamada; Takahiro Tsushima; Seiichiro Mitani; Kazuhiro Shiraishi; Hisateru Yasui; Hiroki Hara; Kenro Hirata; Taito Esaki; Yudai Shinohara; Takao Tsuzuki; Shinya Kajiura; Toshiki Masuishi; Naoki Izawa; Eishi Baba; Kohei Murata; Naoya Akazawa; Yozo Suzuki
Molecular Residual Disease and Recurrence in Rectal Cancer Patients Undergoing Upfront Surgery: A Prospective Cohort Study

分子残留病灶及复发在行术前手术的直肠癌患者中的研究：一项前瞻性队列研究

Annals of Surgery
IF6.4
2025-09-260
OAAI
Ando, Koji MD, PhD; Hamabe, Atsushi MD, PhD; Nakamura, Yoshiaki MD, PhD; Watanabe, Jun MD, PhD; Hirata, Keiji MD, PhD; Kataoka, Kozo MD, PhD; Miyo, Masaaki MD, PhD; Kato, Kentaro MD; Akazawa, Naoya MD; Kagawa, Yoshinori MD, PhD; Yokota, Mitsuru MD, PhD; Yamazaki, Kentaro MD, PhD; Mishima, Saori MD, PhD; Yukami, Hiroki MD; Kotani, Daisuke MD, PhD; Bando, Hideaki MD, PhD; Laliotis, George MD, MHA, MPH, MBA; Sharma, Shruti PhD; Palsuledesai, Charuta C. PhD; Rabinowitz, Matthew PhD; Jurdi, Adham MD; Liu, Minetta C. MD; Aleshin, Alexey MD; Taniguchi, Hiroya MD, PhD; Takemasa, Ichiro MD, PhD; Kato, Takeshi MD, PhD; Yoshino, Takayuki MD, PhD; Oki, Eiji MD, PhD
ctDNA-based molecular residual disease and survival in resectable colorectal cancer

可切除结直肠癌中基于ctDNA的分子残留疾病和生存

NATURE MEDICINE
IF50
2024-09-161
OAAI
Nakamura, Yoshiaki; Watanabe, Jun; Akazawa, Naoya; Hirata, Keiji; Kataoka, Kozo; Yokota, Mitsuru; Kato, Kentaro; Kotaka, Masahito; Kagawa, Yoshinori; Yeh, Kun-Huei; Mishima, Saori; Yukami, Hiroki; Ando, Koji; Miyo, Masaaki; Misumi, Toshihiro; Yamazaki, Kentaro; Ebi, Hiromichi; Okita, Kenji; Hamabe, Atsushi; Sokuoka, Hiroki; Kobayashi, Satoshi; Laliotis, George; Aushev, Vasily N.; Sharma, Shruti; Jurdi, Adham; Liu, Minetta C.; Aleshin, Alexey; Rabinowitz, Matthew; Bando, Hideaki; Taniguchi, Hiroya; Takemasa, Ichiro; Kato, Takeshi; Kotani, Daisuke; Mori, Masaki; Yoshino, Takayuki; Oki, Eiji
Survival benefit of adjuvant chemotherapy based on molecular residual disease detection in resected colorectal liver metastases: Subgroup analysis from CIRCULATE-Japan GALAXY

基于分子残留病灶检测的辅助化疗在切除的结直肠癌肝转移中的生存获益：来自CIRCULATE-Japan GALAXY研究的亚组分析

ANNALS OF ONCOLOGY
IF65.4
2024-09-011
PRE
Kataoka, K.; Mori, K.; Nakamura, Y.; Watanabe, J.; Hirata, K.; Akazawa, N.; Yokota, M.; Kato, K.; Kotaka, M.; Yamazaki, K.; Kagawa, Y.; Sharma, S.; Jurdi, A.; Kotani, D.; Bando, H.; Taniguchi, H.; Takemasa, I.; Kato, T.; Yoshino, T.; Oki, E.
Association of ctDNA-based MRD detection and MRD clearance with short-term overall survival in patients with resectable colorectal cancer: Updated analysis of CIRCULATE-Japan GALAXY

基于ctDNA的微小残留病（MRD）检测与MRD清除与可切除结直肠癌患者短期总生存期的关系：CIRCULATE-Japan GALAXY研究的更新分析

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Nagata, J.; Nakamura, Y.; Watanabe, J.; Akazawa, N.; Ikeda, M.; Yokota, M.; Kato, K.; Kotaka, M.; Yamazaki, K.; Kagawa, Y.; Yeh, K-H.; Laliotis, G.; Jurdi, A.; Kotani, D.; Bando, H.; Taniguchi, H.; Takemasa, I.; Kato, T.; Yoshino, T.; Oki, E.
Final analysis of the JACCRO CC-16: Ramucirumab plus FOLFIRI for RAS wild-type mCRC refractory to anti-EGFR antibody

JACCRO CC-16研究的最终分析：Ramucirumab联合FOLFIRI方案用于对EGFR抗体耐药的RAS野生型mCRC患者

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Sugiyama, K.; Yasui, H.; Nakamura, M.; Sagawa, T.; Kawai, T.; Kataoka, K.; Manaka, D.; Akazawa, N.; Okuno, T.; Shimura, T.; Shiozawa, M.; Sunakawa, Y.; Ota, H.; Kotaka, M.; Okuyama, H.; Okita, Y.; Takeuchi, M.; Ichikawa, W.; Fujii, M.; Tsuji, A.
Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer

基线ctDNA基因改变可作为转移性结直肠癌帕尼单抗和化疗后生存的生物标志物

NATURE MEDICINE
IF50
2024-02-1213
OAAI
Shitara, Kohei; Muro, Kei; Watanabe, Jun; Yamazaki, Kentaro; Ohori, Hisatsugu; Shiozawa, Manabu; Takashima, Atsuo; Yokota, Mitsuru; Makiyama, Akitaka; Akazawa, Naoya; Ojima, Hitoshi; Yuasa, Yasuhiro; Miwa, Keisuke; Yasui, Hirofumi; Oki, Eiji; Sato, Takeo; Naitoh, Takeshi; Komatsu, Yoshito; Kato, Takeshi; Mori, Ikuo; Yamanaka, Kazunori; Hihara, Masamitsu; Soeda, Junpei; Misumi, Toshihiro; Yamamoto, Kouji; Yamashita, Riu; Akagi, Kiwamu; Ochiai, Atsushi; Uetake, Hiroyuki; Tsuchihara, Katsuya; Yoshino, Takayuki
Circulating tumor DNA dynamics as an early predictor of recurrence in patients with radically resected colorectal cancer: GALAXY study in the CIRCULATE-Japan
ANNALS OF ONCOLOGY
IF65.4
2023-11-010
OA
Mishima, Saori; Kotani, Daisuke; Nakamura, Yoshiaki; Bando, Hideaki; Miyo, Masaaki; Hamabe, Atsushi; Watanabe, Jun; Hirata, Keiji; Akazawa, Naoya; Kataoka, Kozo; Yeh, Kun-Huei; Laliotis, George; Jurdi, Adham; Liu, Minetta; Taniguchi, Hiroya; Takemasa, Ichiro; Kato, Takeshi; Yoshino, Takayuki; Oki, Eiji
Postoperative Carbohydrate Antigen 19-9 Level as a Good Indicator of Ineffective Response to the Currently Recommended S-1 Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma: A Single-Center, Retrospective Study

术后糖类抗原19-9水平是胰腺导管腺癌对目前推荐的S-1辅助化疗无效反应的良好指标: 一项单中心回顾性研究

ANNALS OF SURGICAL ONCOLOGY
IF3.5
2023-10-183
PRE
Ariake, Kyohei; Okada, Takaho; Tsuchiya, Haruyuki; Kuboki, Daiki; Maemura, Kimiya; Okada, Yuki; Ichikawa, Hidetaka; Tachibana, Tomoyoshi; Akazawa, Naoya; Abe, Tomoya; Kakita, Tetsuya; Oikawa, Masaya; Tsuchiya, Takashi
Circulating tumor (ct)DNA as a prognostic biomarker in patients (pts) with resected colorectal cancer (CRC): An updated 24 months (mos) disease free survival (DFS) analysis from GALAXY study (CIRCULATE-Japan)
ANNALS OF ONCOLOGY
IF65.4
2023-10-010
OA
Nakamura, Y.; Kotani, D.; Saori, M.; Yukami, H.; Watanabe, J.; Akazawa, N.; Kataoka, K.; Hirata, K.; Yamazaki, K.; Yeh, K-H.; Laliotis, G.; Aushev, V.; Jurdi, A.; Kotaka, M.; Bando, H.; Taniguchi, H.; Takemasa, I.; Kato, T.; Yoshino, T.; Oki, E.
Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With RAS Wild-type, Left-Sided Metastatic Colorectal Cancer A Randomized Clinical Trial

帕尼单抗与贝伐单抗加入标准一线化疗与RAS野生型左侧转移性结直肠癌患者总生存期比较一项随机临床试验

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
IF55
2023-04-1896
OA
Watanabe, Jun; Muro, Kei; Shitara, Kohei; Yamazaki, Kentaro; Shiozawa, Manabu; Ohori, Hisatsugu; Takashima, Atsuo; Yokota, Mitsuru; Makiyama, Akitaka; Akazawa, Naoya; Ojima, Hitoshi; Yuasa, Yasuhiro; Miwa, Keisuke; Yasui, Hirofumi; Oki, Eiji; Sato, Takeo; Naitoh, Takeshi; Komatsu, Yoshito; Kato, Takeshi; Hihara, Masamitsu; Soeda, Junpei; Misumi, Toshihiro; Yamamoto, Kouji; Akagi, Kiwamu; Ochiai, Atsushi; Uetake, Hiroyuki; Tsuchihara, Katsuya; Yoshino, Takayuki

研究方向

暂未获取到该数据
E
Eiji Oki
H 指数:70论文数:1,185被引数:1.8万
T
Takeshi Kato
H 指数:49论文数:664被引数:7,993
I
Ichiro Takemasa
H 指数:59论文数:604被引数:1.4万
M
Mitsuru Yokota
H 指数:16论文数:100被引数:1,131
T
Takayuki Yoshino
H 指数:88论文数:1,566被引数:5.0万
J
Jun Watanabe
H 指数:44论文数:617被引数:8,383
D
Daisuke Kotani
H 指数:26论文数:365被引数:4,170
K
Kozo Kataoka
H 指数:19论文数:163被引数:1,751
M
Masahito Kotaka
H 指数:25论文数:239被引数:2,519
H
Hideaki Bando
H 指数:42论文数:595被引数:7,462